MedTrace Logo

Brain Scintigraphy in Normal Versus Kleine-Levin Syndrome Subjects

NCT02337023 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2015-07-21

No results posted yet for this study

Summary

The investigators perform neuropsychological tests and brain scintigraphy in 30 healthy subjects.

These results will be compared with data obtained out of episode in patients with Kleine-Levin syndrome (KLS).

The investigators want to determine if brain functional imaging and cognitive abnormalities persist during asymptomatic period in a large series of patients with KLS, and to find predictors of these abnormalities.

Conditions

  • Healthy Subjects
  • Kleine-Levin Syndrome

Interventions

RADIATION

Brain scintigraphy with injection of Neurolite® (ECD)

Brain scintigraphy with injection of Neurolite® (ECD) 1 injection

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Isabelle ARNULF, MD, PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02337023 on ClinicalTrials.gov